Baird Raises Price Target on RideNow Group Citing Strong SameStore Sales Performance Xponential Fitness Names Danielle Porto Parra as President in Strategic Leadership Move Citi Boosts Micron Technology Price Target on DRAM Price Surge and HBM Outlook April Jobs Report Expected to Show Modest Gains as Labor Market Cools Mercurys Valuation Surges to 52 Billion as Fintech Recovery Gains Momentum Lowes Faces Reduced Price Target from RBC Capital Amid Market Uncertainties Nordic American Tankers Limited NAT Q4 2025 Earnings EPS Misses Estimates Stock Declines PTCT Q1 2026 Earnings Narrower Loss Surprises Estimates as Stock Dips Slightly VEON Q1 2026 Earnings EPS Beats Estimates Amid Operational Progress TSEM Q1 2026 Earnings Strong EPS Beat Drives Stock Higher CNTA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment OneConstruction Group ONEG Slips 11 Amid Sector Headwinds Key Support Test at 085 Canton Strategic Holdings CNTN Surges 5 Key Levels and Volume Insights Camtek CAMT Pulls Back 29 as Shares Test Key Support Zone Near 161 Charter Communications CHTR Falls 255 as Selling Pressure Persists Near 145 Darling Ingredients DAR Edges Higher as Support Holds Ichor Holdings ICHR Gains 139 as Shares Approach Resistance ASGN Incorporated ASGN Plunges 5169 Key Levels and What Lies Ahead Bragg Gaming Group BRAG Navigates Near Support as Bearish Pressure Persists NVE Corporation NVEC Surges 45 Testing Key Resistance at 9608 Asure Software ASUR Slips 125 as Stock Tests Key Support Zone US Prioritizes American AI Integration in Asia Following TrumpXi Meeting Official Says ALGT Q1 2026 Earnings Solid EPS Beat Masks Revenue Concerns as Shares Slip CNM Q1 2026 Earnings EPS Surpasses Estimates by Nearly 23 Fueled by Strong Demand in Water Infrastructure CGTX Q1 2026 Earnings Cognition Therapeutics Reports NarrowerThanExpected Loss No Revenue Yet First Watch FWRG Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction LCTX Q1 2026 Earnings EPS Miss Weighs on Sentiment as ClinicalStage Biotech Continues Pipeline Progress Voyager Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction GEG Q1 2026 Earnings Significant EPS Miss Pressures Stock ESLA Q1 2026 Earnings EPS Misses Estimates by Wide Margin as ClinicalStage Biotech Continues RD Spending